MediPharm Labs (TSX:LABS) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 19, 2025)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, MediPharm Labs's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of MediPharm Labs's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediPharm Labs's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

MediPharm Labs (TSX:LABS) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

MediPharm Labs Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Executives

Keith Strachan	Director
Gregory Edison Hunter	Senior Officer
David Pidduck	Director, Senior Officer
Bryan Howcroft	Director, Senior Officer
Patrick Mccutcheon	Director
Warren Everitt	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Etf Managers Trust	10% Security Holder
Christopher David Taves	Director
Sybil Taylor	Senior Officer
Braden Fenske	Senior Officer
David John Mayers	Senior Officer